Form: |
Supplied as a liquid in 50mM Tris/HCl pH8.0, 300mM sodium chloride, 0.1mM EGTA, 0.03% Brij-35, 270mM sucrose, 1mM benzamidine, 0.2mM PMSF, 0.1% 2-mercaptoethanol. |
References: |
1. Sadowski M. and Sarcevic B. Mechanisms of Mono- and Poly-Ubiquitination: ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine. Cell Division, 5: 19, 2010. 2. Wenzel D.M. et al. E2s: Structurally Economical and Functionally Replete. Biochem. J., 443: 31-42, 2011. 3. van Wijk S. J. L and Timmers H. T. M. The Family of Ubiquitin-Conjugating Enzymes (E2s):deciding between life and death of proteins. The FASEB Journal, 24: 981-993, 2010. 4. Saville M.K. et al., Regulation of p53 by the Ubiquitin-Conjugating Enzymes UbcH5B/C in vivo. J Biol Chem, 279: 42169-42181, 2004. 5. Gonen H. et al., Identification of the Ubiquitin Carrier Proteins, E2s, Involved in Signal-Induced Conjugation and Subsequent Degradation of IkappaBalpha. J Biol Chem. 274: 14823-14830, 1999. 6. Strack P. et al., SCFb-TRCP and Phosphorylation Dependent Ubiquitination of IkBa Catalysed by Ubc3 and Ubc4. Oncogene, 19: 3529-3536, 2000. |